Gilead Sciences
(NASDAQ) GILD
Gilead Sciences Financials at a Glance
Market Cap
$170.34B
Revenue (TTM)
$29.44B
Net Income (TTM)
$8.51B
EPS (TTM)
$6.78
P/E Ratio
20.23
Dividend
$3.19
Beta (Volatility)
0.42 (Low)
Dividend
$3.19
Beta (Volatility)
0.42 (Low)
Price
$137.24
Volume
15,521,887
Open
$140.43
Price
$137.24
Volume
15,521,887
Open
$140.43
Previous Close
$137.21
Daily Range
$136.49 - $141.00
52-Week Range
$93.37 - $157.29
Dividend
$3.19
Beta (Volatility)
0.42 (Low)
Price
$137.24
Volume
15,521,887
Open
$140.43
Previous Close
$137.21
Daily Range
$136.49 - $141.00
52-Week Range
$93.37 - $157.29
GILD News
GILD: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Gilead Sciences
Industry
Biotechnology
Sector
Health CareEmployees
17,000
CEO
Daniel P. O'Day, MBA
Website
www.gilead.comHeadquarters
Foster City, CA 94404, US
GILD Financials
Key Financial Metrics (TTM)
Gross Margin
81%
Operating Margin
37%
Net Income Margin
29%
Return on Equity
40%
Return on Capital
23%
Return on Assets
14%
Earnings Yield
4.94%
Dividend Yield
0.02%
Payout Ratio
47.04%
Stock Overview
Market Cap
$170.34B
Shares Outstanding
1.24B
Volume
15.52M
Short Interest
0.00%
Avg. Volume
7.02M
Financials (TTM)
Gross Profit
$25.52B
Operating Income
$11.82B
EBITDA
$10.82B
Operating Cash Flow
$10.02B
Capital Expenditure
$563.00M
Free Cash Flow
$9.46B
Cash & ST Invst.
$10.61B
Total Debt
$24.59B
Gilead Sciences Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$7.92B
+4.7%
Gross Profit
$6.88B
+14.9%
Gross Margin
86.84%
N/A
Market Cap
$170.34B
N/A
Market Cap/Employee
$9.68M
N/A
Employees
17,600
N/A
Net Income
$2.18B
+22.4%
EBITDA
$2.33B
-25.0%
Quarterly Fundamentals
Net Cash
$13.99B
+11.2%
Accounts Receivable
$4.91B
+11.2%
Inventory
$4.37B
+155.4%
Long Term Debt
$24.59B
-3.2%
Short Term Debt
$0.00
-100.0%
Return on Assets
14.42%
N/A
Return on Invested Capital
23.30%
N/A
Free Cash Flow
$3.12B
+10.4%
Operating Cash Flow
$3.33B
+11.8%